Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | AMRC | MYRG |
|---|---|---|
| Price | $21.93 | $313.08 |
| Change today | ▼ 3.31% | ▼ 3.52% |
| Market cap | $1.16B | $4.87B |
| Return, 3 months | -14.5% | -27.3% |
| Return, year to date | -25.1% | +43.3% |
| Return, 1 year | -43.2% | +51.2% |
| P/E (TTM) | 41.4 | 29.7 |
| P/B | 0.9 | 6.5 |
| P/E percentile vs own 5y | 80th | 57th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +9.1% | +20.1% |
| Net profit growth (YoY) | +28.3% | +88.4% |
| Gross margin | 16.1% | 12.5% |
| Operating margin | 7.0% | 5.5% |
| Net margin | 1.4% | 4.1% |
| Return on equity | 2.5% | 24.7% |
| Analyst target vs. price | +86.2% | +52.8% |
| Analyst buy share | 67% | 67% |
| RSI (14) | 47 | 58 |
| 30-day volatility | 52.9% | 43.1% |
| Max drawdown, 1 year | -57.2% | -45.9% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
